Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA611884
Max Phase: Preclinical
Molecular Formula: C12H16N4O4S2
Molecular Weight: 344.42
Molecule Type: Small molecule
Associated Items:
ID: ALA611884
Max Phase: Preclinical
Molecular Formula: C12H16N4O4S2
Molecular Weight: 344.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSc1nc(SC)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
Standard InChI: InChI=1S/C12H16N4O4S2/c1-21-10-6-9(14-12(15-10)22-2)16(4-13-6)11-8(19)7(18)5(3-17)20-11/h4-5,7-8,11,17-19H,3H2,1-2H3/t5-,7-,8-,11?/m1/s1
Standard InChI Key: FTGZLZPNEHEUMH-YNJARDAQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 344.42 | Molecular Weight (Monoisotopic): 344.0613 | AlogP: -0.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 113.52 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.45 | CX Basic pKa: 2.05 | CX LogP: 0.67 | CX LogD: 0.67 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.40 | Np Likeness Score: 0.31 |
1. Krenitsky TA, Rideout JL, Koszalka GW, Inmon RB, Chao EY, Elion GB, Latter VS, Williams RB.. (1982) Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines., 25 (1): [PMID:7086819] [10.1021/jm00343a007] |
Source(1):